Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Exercise × 30 days × Clear all

Sponsor

Conditions

Motor Activity 7 Breast Neoplasms 3 Obesity 2 Neoplasms 2 Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphedema 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

pembrolizumab 10 Cisplatin 7 Radiotherapy 5 Gemcitabine 5 Carboplatin 5 Paclitaxel 4 Human Papillomavirus DNA Tests 4 Fulvestrant 4 Bevacizumab 4 zimberelimab 3 tisotumab vedotin 3 Topotecan 3 Specimen Handling 3 Restraint, Physical 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 Colposcopy 3 Brachytherapy 3 spartalizumab 2 lenvatinib 2 Vinorelbine 2 Radiation 2 Platinum 2 Nivolumab 2 Irinotecan 2 IFL protocol 2 Drug Therapy 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡